Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIPIN pseudogene 2 (TIPINP2) is a human pseudogene related to the TIMELESS interacting protein (TIPIN)[3]. Pseudogenes are genomic DNA sequences similar to known genes but typically lack the ability to code for functional proteins due to disabling mutations such as insertions, deletions, or premature stop codons[6]. TIPIN itself is involved in DNA replication and cell cycle control, but TIPINP2 does not encode a functional product and is not considered a therapeutic target, receptor, enzyme, transporter, or biomarker. Pseudogenes like TIPINP2 may have regulatory roles or act as miRNA decoys, influencing gene expression indirectly, but there is no specific evidence for TIPINP2’s involvement in such mechanisms[1][5]. There are no known drugs or therapies targeting TIPINP2, and it does not serve as a safety concern, biomarker, or mechanistic focus in clinical medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TIPIN pseudogene 2 (TIPINP2).